Tenaya Therapeutics to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference
November 19 2021 - 8:00AM
Business Wire
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology
company with a mission to discover, develop and deliver curative
therapies that address the underlying causes of heart disease,
announced today that Faraz Ali, Chief Executive Officer, will
participate in the following conference:
33rd Annual Piper Sandler Healthcare Conference November
29 – December 2, with a fireside chat webcast available beginning
Monday, November 22, 2021 at 10:00 a.m. ET / 7:00 a.m. PT
About Tenaya Therapeutics
Tenaya Therapeutics is a biotechnology company committed to a
bold mission: to discover, develop and deliver curative therapies
that address the underlying drivers of heart disease. Founded by
leading cardiovascular scientists from Gladstone Institutes and the
University of Texas Southwestern Medical Center, Tenaya is
developing therapies for rare genetic disorders as well as for more
prevalent heart conditions through three distinct but interrelated
product platforms: Gene Therapy, Cellular Regeneration and
Precision Medicine. For more information, visit
www.tenayatherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211119005241/en/
Investors: Leone Patterson Tenaya Therapeutics
IR@tenayathera.com
Media: Wendy Ryan Ten Bridge Communications
wendy@tenbridgecommunications.com
Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From Jul 2023 to Jul 2024